| Chemo Pharma Laboratories Ltd Industry: (Pharmaceuticals - Indian - Bulk Drugs) |
|---|
|
BSE Code:
506365
ISIN Demat:
INE320M01019
Book Value(₹): 87.60 NSE Symbol: N.A Div & Yield(%):
N.A
Market Cap(₹ Cr): 19.28 P/E(TTM):
56.38
EPS(TTM):
2.28
Face Value(₹): 10.00 |
| Particulars | Mar 2025 (₹ Cr) | Dec 2024 (₹ Cr) | Sep 2024 (₹ Cr) |
|---|---|---|---|
| Gross Sales | 0.00 | 0.00 | 0.00 |
| Excise Duty | 0.00 | 0.00 | 0.00 |
| Net Sales | 0.00 | 0.00 | 0.00 |
| Other Operating Income | 0.00 | 0.00 | 0.00 |
| Other Income | -0.16 | -0.15 | 0.63 |
| Total Income | -0.16 | -0.15 | 0.63 |
| Total Expenditure | 0.02 | 0.02 | 0.02 |
| PBIDT | -0.18 | -0.17 | 0.61 |
| Interest | 0.00 | 0.00 | 0.00 |
| PBDT | -0.18 | -0.17 | 0.61 |
| Depreciation | 0.00 | 0.00 | 0.00 |
| Tax | 0.20 | 0.00 | 0.00 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.04 | 0.00 | 0.00 |
| Reported Profit After Tax | -0.34 | -0.17 | 0.61 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | -0.34 | -0.17 | 0.61 |
| EPS (Unit Curr.) | -2.26 | -1.17 | 4.07 |
| EPS (Adj) (Unit Curr.) | -2.26 | -1.17 | 4.07 |
| Calculated EPS (Unit Curr.) | -2.26 | -1.17 | 4.07 |
| Calculated EPS (Adj) (Unit Curr.) | -2.26 | -1.17 | 4.07 |
| Calculated EPS (Ann.) (Unit Curr.) | -9.06 | -4.66 | 16.27 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | -9.06 | -4.66 | 16.27 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 |
| Equity | 1.50 | 1.50 | 1.50 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 0.00 | 0.00 | 0.00 |
| PBDTM(%) | 0.00 | 0.00 | 0.00 |
| PATM(%) | 0.00 | 0.00 | 0.00 |
